|
Literature / Source Database:
Molecular Pharmaceutics
| Title (short) |
Mol. Pharm. |
| CODEN |
MPOHBP |
| Languages |
English |
| First year |
2004 |
| Impact factor |
5.364 |
| Editor |
Lynne S. Taylor |
|
|
|
Status
active
Indexing
CAS, SCOPUS, EBSCOhost, Proquest, British Library, PubMed, CABI, Ovid, Web of Science, and SwetsWise.
Subject
Source type
Journal
Publisher
ISBN ISSN
1543-8384
E ISSN
1543-8392
First volume
1
Last volume
20+
Publish city
Washington
Homepage
| Resources |
|
Availability |
|
|
|
|
|
| Text PDF |
 |
free access |
 |
| Text Html |
 |
for subscriber |
|
| References |
|
not available |
|
| Abstracts |
|
|
|
| TOC |
|
|
|
|
|
|
|
Description
Molecular Pharmaceutics publishes original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. Modalities of interest include small molecules, imaging agents, proteins, peptides, vaccines, cell and gene-based therapies, and their characterization, formulation, and delivery. Scientific areas within the scope of the journal include: - Modelling and simulation to aid mechanistic insights into drug delivery
- Molecular understanding of formulations
- Formulation performance under physiological conditions
- Materials science as it relates to drug, excipients and drug delivery system efficacy.
- Emerging techniques and technologies for drug delivery including theranostics, precision medicine and artificial intelligence
Theoretical and experimental peer-reviewed full-length research papers, critical reviews, perspectives, and communications are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.
|
